Skip to content

Post Marketing Clinical Evaluation Assessing the Visual Performance of Hanita Lenses Intensity SL Intraocular Lens

Post Marketing Clinical Evaluation Assessing the Visual Performance of Hanita Lenses Intensity SL Intraocular Lens

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06075459
Acronym
Post-op
Enrollment
60
Registered
2023-10-10
Start date
2023-03-01
Completion date
2023-09-05
Last updated
2023-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

Cataract, IOL, Hanita Lenses

Brief summary

This clinical study will assess the safety and performance of Intensity SL IOL, 1 year post operation. The study will also evaluate the patient satisfaction of the implanted patients.

Detailed description

Study Design: This study is an ambispective, single arm single center, open label study. Study Objectives: The aim of this study is to evaluate performance of Hanita Lenses Intensity SL IOL. The primary aim of this study is to evaluate the binocular defocus Curve and visual acuity for far, intermediate and near distance after Intensity SL IOL implantation. The second aim of this study is to evaluate the patient satisfaction 12 to 24 months post-operation. Study population: Men and women who had implantation on both eyes using Hanita Lenses SeeLens SL IOL, for 12 to 24 months post operation. Enrollment: The study will encompass a total of 60 eligible subjects implanted bilaterally (120 eyes) in total who will complete the protocol follow-up schedule. Duration of Subject participation: Duration of Subject participation is at most one month Completion of active enrolment is anticipated to last approximately 6 months. The primary aim will be finally evaluated when the last study subject has been recruited. Visits & Procedures Patients participating in the trial will attend a total of one visit (1 year follow up visit). Subjects will be selected from the physician's usual subjects' practice. All subjects meeting the inclusion criteria and having signed the Informed Consent Form will be evaluated by the Investigator according to the study protocol. 1 year follow up visit: Pre-operation Visit: performed to check inclusion criteria, and to sign the informed consent.

Interventions

None listed

Sponsors

Hanita Lenses
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Implanted bilaterally using Hanita Intensity SL IOL * 12 to 24 months post implantation * Signed informed consent

Exclusion criteria

• Patients with any other pre-implantation and post implantation eye disease or condition that might affect the safety and efficacy evaluation.

Design outcomes

Primary

MeasureTime frameDescription
The aim of this study is to evaluate performance of Hanita Lenses Intensity SL IOL.21-24 months post operationPerformance of the IOL will be evaluated by assessing the defocus Curve and visual acuity for far, intermediate and near distance after Intensity SL IOL implantation.

Secondary

MeasureTime frameDescription
The second aim of this study is to evaluate the patient satisfaction post-operation.21-24 months post operationPatient satisfaction will be evaluated by using Quality of Life (VH14) and satisfaction Questionnaire

Countries

Argentina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026